Objetivo A large number of surgeries, over 50 million per year worldwide, from Caesarean section to hip replacements, require continuous blood pressure (BP) monitoring. Until today, no non-invasive method exists that is suitable for clinical practice, thus making monitoring this vital sign unnecessarily painful, risky, time-consuming, and expensive. The majority of patients (80%) do not receive continuous BP monitoring. This lack of control increases the peri- and postoperative risk for these patients significantly. ImPress MedTech GmbH is a medical technologies company whose aim is to implement simple-to-use, non-invasive, continuous BP measurement as a new clinical standard. With the SmartNiBP project, ImPress MedTech aims to fully develop and commercialize a proprietary medical device that uses innovative technology based on impedance cardiography to provide continuous non-invasive BP measurement. The technology is inexpensive, robust, and uses a clinically well-known setup. SmartNiBP ties easily into existing multi-parameter monitoring equipment and requires no extra training. SmartNiBP will be commercialized in 3 years as a SmartNiBP monitor unit and SmartNiBP disposable electrodes, with an expected ROI of 7.68. With SmartNiBP’s disruptive technology for BP measuring, patients will be spared pain and the risk of complications.Conceived as a medical device, our stand-alone soft&hardware solution is able to reliably support the surgeon throughout the arduous decision-making routine incurred in surgeries and any operational procedures where continuous BP measurement is needed. The result will be a large improvement in patient outcomes and a reduction in healthcare costs. SmartNiBP we will first designed for hospital settings, but it could be equally quickly adapted to other clients. Especially we are interested in mobile devices, BP monitoring for medicated individuals, sports medicine or healthcare of the elderly. Ámbito científico medical and health sciencesclinical medicinesurgerysurgical proceduresmedical and health sciencesclinical medicineanaesthesiology Programa(s) H2020-EU.2.1.1. - INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies - Information and Communication Technologies (ICT) Main Programme H2020-EU.2.3.1. - Mainstreaming SME support, especially through a dedicated instrument Tema(s) SMEInst-01-2016-2017 - Open Disruptive Innovation Scheme Convocatoria de propuestas H2020-SMEInst-2016-2017 Consulte otros proyectos de esta convocatoria Convocatoria de subcontratación H2020-SMEINST-1-2016-2017 Régimen de financiación SME-1 - SME instrument phase 1 Coordinador IMPRESS MEDTECH GMBH Aportación neta de la UEn € 50 000,00 Dirección NEUE STIFTINGTALSTRASSE 2A 8010 GRAZ Austria Ver en el mapa Pyme Organización definida por ella misma como pequeña y mediana empresa (pyme) en el momento de la firma del acuerdo de subvención. Sí Región Südösterreich Steiermark Graz Tipo de actividad Private for-profit entities (excluding Higher or Secondary Education Establishments) Enlaces Contactar con la organización Opens in new window Participación en los programas de I+D de la UE Opens in new window Red de colaboración de HORIZON Opens in new window Coste total € 71 429,00
